Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On testing for bioequivalence.

D M Rocke

    Biometrics
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel statistical method for analyzing bioequivalence trials. The new approach is compared with existing techniques, offering practical guidance for statistical testing in pharmaceutical research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetic and pharmacodynamic analysis comparing diverse effects of detomidine, medetomidine, and dexmedetomidine in the horse: a population analysis.

    Journal of veterinary pharmacology and therapeutics·2014
    Same author

    IGF-1 does not moderate the time-dependent transcriptional patterns of key homeostatic genes induced by sustained compression of bovine cartilage.

    Osteoarthritis and cartilage·2009
    Same author

    A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins.

    Molecular psychiatry·2006
    Same author

    Group assessment: elemental speciation.

    Ecotoxicology and environmental safety·2003
    Same author

    A variance-stabilizing transformation for gene-expression microarray data.

    Bioinformatics (Oxford, England)·2002
    Same author

    A model for measurement error for gene expression arrays.

    Journal of computational biology : a journal of computational molecular cell biology·2001
    Same journal

    Acknowledgment of Referees 2025.

    Biometrics·2026
    Same journal

    Fast penalized generalized estimating equations for large longitudinal functional datasets.

    Biometrics·2026
    Same journal

    Causally-interpretable random-effects meta-analysis.

    Biometrics·2026
    Same journal

    Statistical inference for mean function of partially observed functional time series.

    Biometrics·2026
    Same journal

    Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

    Biometrics·2026
    Same journal

    Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

    Biometrics·2026
    See all related articles

    Area of Science:

    • Biostatistics
    • Pharmacokinetics
    • Clinical Trial Design

    Background:

    • Bioequivalence trials are crucial for demonstrating therapeutic equivalence between drug products.
    • Statistical analysis is essential for interpreting the results of these trials.
    • Existing statistical methods for bioequivalence trials have limitations.

    Purpose of the Study:

    • To propose a new statistical method for analyzing bioequivalence trials.
    • To compare the proposed method with three existing techniques.
    • To provide practical recommendations for statistical testing in bioequivalence studies.

    Main Methods:

    • Development of a novel statistical approach for bioequivalence assessment.
    • Comparative analysis of the proposed method against three established techniques.

    Related Experiment Videos

  • Evaluation of statistical test performance and relationships among methods.

    • Main Results:

    • The proposed method demonstrates distinct advantages in certain scenarios.
    • The study clarifies the interrelationships between the four statistical methods.
    • Practical suggestions for selecting appropriate statistical tests are provided.

    Conclusions:

    • The new statistical method offers a valuable alternative for bioequivalence trial analysis.
    • Understanding the relationships between methods aids in optimal test selection.
    • The findings contribute to more robust statistical practices in pharmaceutical development.